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Abstract
Background: Increased reports of Neisseria meningitidis urethritis in multiple U.S. cities during 2015 have been
attributed to the emergence of a novel clade of nongroupable N. meningitidis within the ST-11 clonal complex, the
“U.S. NmNG urethritis clade”. Genetic recombination with N. gonorrhoeae has been proposed to enable efficient
sexual transmission by this clade. To understand the evolutionary origin and diversification of the U.S. NmNG
urethritis clade, whole-genome phylogenetic analysis was performed to identify its members among the N.
meningitidis strain collection from the Centers for Disease Control and Prevention, including 209 urogenital and
rectal N. meningitidis isolates submitted by U.S. public health departments in eleven states starting in 2015.
Results: The earliest representatives of the U.S. NmNG urethritis clade were identified from cases of invasive disease
that occurred in 2013. Among 209 urogenital and rectal isolates submitted from January 2015 to September 2016, the
clade accounted for 189/198 male urogenital isolates, 3/4 female urogenital isolates, and 1/7 rectal isolates. In total,
members of the clade were isolated in thirteen states between 2013 and 2016, which evolved from a common
ancestor that likely existed during 2011. The ancestor contained N. gonorrhoeae-like alleles in three regions of its
genome, two of which may facilitate nitrite-dependent anaerobic growth during colonization of urogenital sites.
Additional gonococcal-like alleles were acquired as the clade diversified. Notably, one isolate contained a sequence
associated with azithromycin resistance in N. gonorrhoeae, but no other gonococcal antimicrobial resistance
determinants were detected.
Conclusions: Interspecies genetic recombination contributed to the early evolution and subsequent diversification of
the U.S. NmNG urethritis clade. Ongoing acquisition of N. gonorrhoeae alleles by the U.S. NmNG urethritis clade may
facilitate the expansion of its ecological niche while also increasing the frequency with which it causes urethritis.
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Background
Neisseria meningitidis is primarily recognized as a cause
of invasive, life-threatening infections such as meningitis
and septicemia [1]. However, N. meningitidis is also an
occasional cause of other infections, including urethritis
[2–6]. Several isolates from cases of meningococcal ur-
ethritis in France and Germany were recently found to
be closely related to isolates from cases of invasive men-
ingococcal disease among men who have sex with men
(MSM) in these countries [7], reviving a hypothesis that
urethral colonization may contribute to invasive disease
among MSM [8–10]. Recently, notable increases in the
number of N. meningitidis urethritis cases were reported
from two U.S. sexually transmitted disease clinics in
Columbus, Ohio and Oakland County, Michigan [11].
For instance, in Columbus, N. meningitidis was isolated
from 75 urethritis cases between January and November
of 2015, equal to a quarter of the N. gonorrhoeae isolated
during that period [12].
These N. meningitidis isolates formed a novel, urethritis-
associated clade [12], which also includes recently de-
scribed urethritis isolates from Georgia and Indiana [8, 13].
This clade is part of the hypervirulent lineage 11 of N.
meningitidis, corresponding to the ST-11 clonal complex
(CC11) [14]. This is the same lineage associated with sev-
eral outbreaks of invasive meningococcal disease among
MSM [7, 15–18]. Unlike the isolates from meningitis
outbreaks among MSM, which were assigned to N. menin-
gitidis serogroup C (NmC) due to the structure and im-
munogenic properties of their bacterial capsules, the
urethritis-associated isolates identified by Bazan et al. [12]
are nongroupable N. meningitidis (NmNG) because of a
multi-gene deletion at the capsule synthesis locus [8]. The
bacterial capsule influences traits such as resistance
to serum bactericidal activity and adhesion to epithe-
lial cells [19]. The capsule is notably absent from uro-
genital pathogen N. gonorrhoeae, which is the most
closely related species to N. meningitidis and a com-
mon cause of urethritis [20].
The clade identified by Bazan et al. [12] (hereafter, the
“U.S. NmNG urethritis clade”) is also similar to N.
gonorrhoeae in that the isolates are capable of nitrite
dependent anaerobic growth [8]. This phenotype corre-
sponds to the presence of gonococcal-like aniA and
norB genes, which catalyze the conversion of nitrite to
nitrous oxide, by way of nitric oxide. Gene flow between
N. meningitidis and N. gonorrhoeae has rarely been de-
tected [20, 21], so acquisition of aniA and norB from N.
gonorrhoeae through homologous recombination raises
the prospect that other loci may also undergo horizontal
gene transfer between these two exclusively human-
colonizing bacteria. Transfer of antimicrobial resistance
determinants are of particular concern, since antimicro-
bial resistance is common in N. gonorrhoeae [22, 23] but
rare in N. meningitidis in the United States [24]. Illus-
trating this risk, a N. meningitidis strain with a N. gonor-
rhoeae penicillin resistance-associated penA allele was
recently reported from an invasive meningococcal disease
case involving a patient on long-term complement inhibi-
tor therapy and daily penicillin chemoprophylaxis [25].
The Gonococcal Isolate Surveillance Project (GISP) is a
network of 27 sexually transmitted disease clinics that
routinely collect isolates from men with signs or symp-
toms of urethritis in order to monitor trends in antimicro-
bial susceptibility in N. gonorrhoeae [11, 23]. Urethral
infections involving the U.S. NmNG urethritis clade were
initially identified at two GISP sentinel sites by the pres-
ence of discordant laboratory test results: observation of
gram-negative intracellular diplococci (GNID) in urethral
secretions and growth of oxidase-positive bacterial col-
onies on selective media (Modified Thayer-Martin), but
negative results for N. gonorrhoeae nucleic acid amplifica-
tion testing (NAAT) of urine [11]. The Centers for Disease
Control and Prevention (CDC) subsequently requested
that public health laboratories submit cultures of sus-
pected N. meningitidis isolated from body sites typically
associated with N. gonorrhoeae infection, including the
rectum and urogenital tract.
The genomes of these N. meningitidis isolates were se-
quenced to assess whether additional clades of N. menin-
gitidis are associated with urethritis and to characterize
the geographic distribution of the previously identified
U.S. NmNG urethritis clade. Further analyses were con-
ducted to identify cases of invasive disease involving the
U.S. NmNG urethritis clade, the evolutionary relationship
between N. meningitidis urethritis isolates and invasive
disease isolates from MSM, and the genetic changes that
corresponded to the emergence of this novel urethritis
pathogen.
Results
The U.S. NmNG urethritis clade includes invasive disease
isolates
Twelve isolates in the CDC N. meningitidis strain
collection were identified as belonging to the U.S.
NmNG urethritis clade, not including isolates that
were submitted in response to the previously de-
scribed clusters of N. meningitidis urethritis (i.e. uro-
genital and rectal isolates collected after January 1,
2015, described below). All 12 isolates were non-
groupable. Of these 12 isolates, five were from pa-
tients with invasive disease that occurred between
2013 and 2016. Two of the five were cultured from
cerebrospinal fluid (CSF) of patients with meningitis
and the remaining three isolates were cultured from
the blood of patients. Four of the five patients were
males (two of whom had sex with men) and one was
female.
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The remaining seven U.S. NmNG urethritis clade iso-
lates identified within the CDC strain collection were
not from invasive disease. One male urogenital isolate
was recovered in New York in 2013, and another was
recovered in Michigan in 2014. Three isolates were col-
lected from the mouth and throat, where one originated
from an oral swab provided by a sexual partner of a
urethritis patient previously known to be infected by an
isolate from the U.S. NmNG urethritis clade. An add-
itional two isolates were collected from eye swabs.
Most recent urethritis isolates belong to the U.S. NmNG
urethritis clade
As a result of the CDC request to state and local public
health departments (see Methods), a total of 209 N.
meningitidis isolates collected from urogenital and rec-
tal sites between January 1, 2015 and September 30,
2016 were obtained, sequenced, and analyzed (Table 1,
Additional file 1). This included 75 previously described
urethral isolates from Columbus, Ohio [12]. Isolates
collected from the male urogenital system (n = 198)
were recovered in 11 states. The remaining isolates (n = 11)
were from the rectum or female urogenital system, which
also were recovered in three of those states. The vast
majority of isolates (n = 195) belonged to CC11, with
the remaining 14 isolates (six rectal and eight uro-
genital) belonging to 14 different clonal complexes
(three of which are not formally designated).
A SNP-based phylogeny of these 209 isolates was
inferred to identify clades associated with urogenital
or rectal colonization, as well as their relationship to
144 isolates from urogenital and invasive meningococ-
cal disease cases, among both MSM and non-MSM
patients. (Fig. 1; collection described in methods and
Additional files 1 and 2). The U.S. NmNG urethritis
clade is in sublineage 11.2, and included 193 of the
209 isolates submitted for this study (189 male urogenital,
three female urogenital, one rectal). Two additional
NmNG urethral isolates submitted for this study were also
in sublineage 11.2, and were most closely related to each
other (Fig. 1, blue star, 99.9% bootstrap support). The
remaining 14 urogenital and rectal isolates submitted for
this study were distantly related from each other and the
lineage 11 isolates.
Among the 144 isolates compared to the U.S. urogenital
and rectal isolates, the closest relatives were among the 44
CC11 isolates from invasive case-patients who are not
known to be MSM. The 33 CC11 urogenital isolates from
outside the United States (Fig. 1, white in third ring, blue
in outer ring) were not the closest relatives of any urogeni-
tal or rectal isolates collected in the United States (black
in third ring, blue in outer ring); nor were the 38 CC11
isolates from invasive cases among MSM (Fig. 1, circle on
branch tip, red in outer ring).
Isolates from invasive cases among MSM in the
United States were phylogenetically dispersed among
isolates from invasive cases among non-MSM patients,
except for previously described outbreaks [16–18, 26].
However, two European isolates from invasive cases
among MSM were similar to two different groups of
U.S. isolates collected during outbreaks of invasive dis-
ease among MSM (Fig. 1, asterisks; LNP27256 from
France and M11 240,294 from the U.K.).
Besides the 193 isolates submitted for this study and
12 isolates identified among the genomes in the CDC
strain collection (as described above), the U.S. NmNG
urethritis clade also included four urethral isolates from
Indiana with publicly available genome assemblies.
The remaining isolates in this analysis were three
invasive NmNG isolates belonging to CC11, CC192,
and CC41/44, two sublineage 11.1 genomes included
as phylogenetic references (FAM18 and the serogroup
W Hajj-related outbreak isolate M07149), and eight
invasive disease isolates identified as the closest rela-
tives of the U.S. NmNG urethritis clade in the CDC
strain collection. They were collected from invasive
cases in 2007 and 2008; seven were NmC and one
was NmNG.
The U.S. NmNG urethritis clade has recently spread to
multiple states
The 209 isolates belonging to the U.S. NmNG urethritis
clade were collected in 13 different states between 2013
and 2016 (Additional file 1). To estimate the evolution-
ary timeline of this clade, the relationships among the
clade and closely related isolates was inferred using
BEAST v1.8.3 [27], which models evolution with a mo-
lecular clock (Fig. 2). This analysis included 204 of the
209 U.S. NmNG urethritis clade isolates, with five ex-
cluded because high-quality read data was not available
(see methods). To provide an outgroup, the analysis
included the eight closest relatives to the U.S. NmNG
urethritis clade from the CDC strain collection. An
additional closely related NmC isolate with a complete
genome sequence (M21273) was included as a reference
for sequence alignment.
Table 1 Urogenital and rectal N. meningitidis isolates submitted
to the CDC: January 2015–September 2016
Year Serogroup
Body site Total 2015 2016 NG B Y
Male urogenital system 198 124 74 196 1 1
Rectum 7 6 1 3 4 0
Female urogenital system 4 2 2 4 0 0
Total 209 132 77 203 5 1
NG = nongroupable
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The U.S. NmNG urethritis clade was estimated to have
diverged from the eight closely related invasive disease
isolates at 2006.3 (Fig. 2, node b; 95% HPD interval
= [2005.8, 2006.7]). The U.S. NmNG urethritis clade was
confidently identified as a separate branch from the
closely related invasive disease isolates (Bayesian posterior
clade probability = 1), with its most recent common an-
cestor estimated to have existed at 2011.4 (Fig. 2, node c;
95% HPD interval = [2010.8, 2012.0]). Within the ureth-
ritis clade, the vast majority of isolates from Columbus,
Ohio (112/117) belonged to a strongly supported clade
with no isolates from other states (Fig. 2, node d; posterior
probability = 1), and its most recent common ancestor
was estimated to have existed at 2014.1 (95% HPD inter-
val = [2013.7, 2014.3]). In addition to 111 isolates obtained
from urethral swabs at the Columbus clinic, this clade in-
cluded one isolate obtained from an oral swab at the same
clinic.
Isolates submitted from other states were phylogenet-
ically dispersed (Fig. 2). Three of the five isolates from
normally sterile sites of patients with invasive meningo-
coccal disease were isolated in states that also submitted
isolates from the urogenital system, yet the isolates from
normally sterile sites were not closely related to the uro-
genital isolates from the same state.
The U.S. NmNG urethritis clade has few changes in gene
content
Using the same set of isolates as shown in Fig. 2, gene
content variation among 204 U.S. NmNG urethritis
clade isolates and the eight most closely related invasive
meningococcal disease isolates were examined to iden-
tify gain or loss of genes. Consistent with previous find-
ings, all 204 U.S. NmNG urethritis clade isolates lacked
the capsule synthesis genes cssA, cssB, and cssC, and
retained only a partial (“incomplete”) csc gene sequence.
Only one other coding sequence, NEIS1859 (autA,
autotransporter A), was absent in all members of the ur-
ethritis clade but present in more than four of the
closely related invasive meningococcal disease isolates.
NEIS1859 was reported as “incomplete” in the U.S.
NmNG urethritis clade genome assemblies, but it was
reported as allele 326 in the seven closely related NmC
genomes and missing in the closely related genome of
NmNG M16917. This locus was confirmed to contain
IS1301 in all members of the U.S. NmNG urethritis
Fig. 1 SNP parsimony phylogeny of 353 N. meningitidis isolates. Isolates are marked to indicate the serogroup (inner ring), year of isolation
(second ring), whether collected in the USA (third ring), the body site from which they were isolated (outer ring), and whether the patient was a
MSM (circles on branch tips). Counts in the key refer to isolates outside of the U.S. NmNG urethritis clade. The 209 isolates of the U.S. NmNG
urethritis clade are collapsed, with details presented in Fig. 2. Additional labels identify the lineage 11 branch, the branches for sublineages 11.1
and 11.2, two European isolates from MSM that are closely related to U.S. isolates from MSM (asterisks), and two closely related NmNG urethritis
isolates within sublineage 11.2 (blue star). The scale bar represents 250 substitutions within the 8607 core SNP alignment
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clade based on the mapping of paired reads to both
IS1301 and NEIS1859 using ISMapper v1.2 [28].
No gene was contained by more than two of the
204 U.S. NmNG urethritis clade genomes without also
being contained by at least one of the eight closely re-
lated outgroup genomes. The nadA (NEIS1969) locus
was disrupted by IS1301 in the eight closely related inva-
sive meningococcal disease isolates and the reference
genome M21273 (allele 29), but the IS element was
absent from the nadA locus in 192 of the 204 genomes
belonging to the urethritis clade (Additional file 1).
Gene flow from N. gonorrhoeae has affected the U.S.
NmNG urethritis clade
The acquisition of genetic material through horizontal
gene transfer was explored using ClonalFrameML [29]
to identify regions of the core genome alignment where
divergent DNA sequences were incorporated into the
genomes of these isolates. In total, 581 recombination
events were identified along the BEAST-generated tree
(Fig. 2; Additional file 3), with estimated parameters of
R/theta = 0.41 (ratio of recombination events to point
mutation events), nu = 3.7% (mean polymorphisms per
recombinant tract), and delta = 1253 bp (mean recom-
bination tract length). Of these 581 recombination
events, 64 were on the branch leading to the outgroup
(Fig. 2, dashed branches from root node a), 18 on
branches leading to the closely related invasive meningo-
coccal disease isolates (Fig. 2, solid branches basal to
node b; total length 3.96 × 10− 5 substitutions per site),
eight on the branch leading to the root of the U.S.
NmNG urethritis clade (Fig. 2, branch between nodes b
and c; length 1.51 × 10− 5), and 491 within the U.S.
NmNG urethritis clade (Fig. 2, node c; total length of
8.95 × 10− 4).
Recombinant sequences were used as BLAST queries
to search the NCBI RefSeq Genomic DNA library,
identifying matches for 515 of the sequences (Additional
file 3). The remaining 66 small recombination events in-
cluded no more than 39 nucleotides each, representing
271 substitutions in total. Within the U.S. NmNG ureth-
ritis clade, 429 recombinant sequences matched RefSeq
genomes, of which 145 were inferred to have originated
from a species other than N. meningitidis. N. gonor-
rhoeae was the inferred source for 138 recombination
events, while N. lactamica and N. cinerea were each the
Fig. 2 Time-measured Bayesian phylogeny U.S. NmNG urethritis clade. The analysis included 204 isolates belonging to the clade, with nine
closely related invasive isolates used as an outgroup. Isolates are marked according to the state in which they were isolated (symbols on branch
tips), and body site from which they were isolated (colored ring). Counts in the key refer to isolates in the U.S. NmNG urethritis clade. Nodes
mentioned in the text are marked with black circles and labeled with the estimated year: (a) the root; (b) divergence between urethritis clade
and NmC isolates, (c) the U.S. NmNG urethritis clade; and (d) the clade comprising solely isolates from Columbus, OH. The two branches
originating at the root (node “a”) are dashed to indicate that inferred mutational events on the branch leading to the outgroup cannot be
oriented with respect to time. The scale bar represents 1 year
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inferred source for two events. N. polysaccharea was the
inferred source for one recombinant sequence, and two
recombinant sequences matched the genomes of un-
specified Neisseria spp. Of the remaining 284 recombin-
ant sequences with hits, 272 were most similar to N.
meningitidis sequences, while 12 had ambiguous origins.
Along the branch leading to the most recent common
ancestor of the U.S. NmNG urethritis clade, three of the
eight recombinant sequences with matches to RefSeq
genomes were inferred to have originated in N. gonor-
rhoeae, with three originating from other N. meningitidis
genomes and two being of ambiguous origin. Along the
branches leading to the eight invasive meningococcal
disease isolates not belonging to the U.S. NmNG ureth-
ritis clade, only one of 17 recombinant sequences with
matches in the RefSeq database was inferred to have
originated from another species, N. gonorrhoeae, affect-
ing only a single genome (M16917).
The ancestors of the U.S. NmNG urethritis clade were
inferred to have acquired N. gonorrhoeae alleles in three
genomic regions containing a total of 7638 bp and eight
genes (Additional file 4). One recombination event
covered 42% of the acetylglutamate kinase gene argB
(NEIS1038) and changed 3.4% of nucleotides, resulting
in 100% sequence identity to N. gonorrhoeae. A second
recombination event covered 100% of the nitrite-
reductase gene aniA (NEIS1549) and 96% of the nitric
oxide reductase gene norB (NEIS1548), and changed
4.8% of nucleotides, resulting in 99.8% identity to N.
gonorrhoeae. A third recombination event covered 85%
of the 2-C-methyl-D-erythritol 4-phosphate cytidylyl-
transferase gene ispD (NEIS1442) and all of the adjacent
four loci (NEIS1443–1446): the DNA polymerase III
subunit epsilon gene dnaQ, a homolog of the lysopho-
spholipid transporter gene lplT, a homolog of a cbb3-
type cytochrome oxidase maturation protein fixS, and a
conserved hypothetical protein. This recombination
event changed 3.7% of nucleotides, resulting in a se-
quence with 98.5% identity to N. gonorrhoeae.
Recombination events identified within the U.S. NmNG
urethritis clade (including the most recent common an-
cestor) totaled 864,056 base pairs (bp), but because some
events overlapped, only 556,610 bp of the alignment were
affected by at least one recombination event. Cross-
species recombination events affected 274,420 bp, with
262,267 bp being affected by events inferred to involve N.
gonorrhoeae DNA. The total length of DNA sequences in-
ferred to have originated from N. gonorrhoeae varied sub-
stantially among the 204 members of the U.S. NmNG
urethritis clade (Fig. 3, Additional file 1). While several of
the isolates contained only the gonococcal DNA present
in the common ancestor (7638 bp in three regions), others
had as much as 30,208 bp. Furthermore, others had as lit-
tle as 5713 bp due to acquisition of non-gonococcal DNA
sequences during subsequent recombination events at the
loci that had contained gonococcal sequences in the most
recent common ancestor. Gonococcal DNA was identified
in 268 of the 2256 loci annotated by PubMLST for
M21273, covering at least 50% of the locus in at least one
genome. Similarly, gonococcal DNA was identified in 249
of the 2045 loci annotated by Prokka (Additional file 4).
Several loci were impacted by multiple recombination
events (Additional file 4). For the three stretches of
gonococcal DNA contained by the most recent common
ancestor of the U.S. NmNG urethritis clade (totaling
7638 bp and including eight PubMLST loci), two regions
were involved in subsequent recombination events that
affected five PubMLST loci. The aniA and norB genes
(NEIS1458 and NEIS1459) were involved in three subse-
quent recombination events. One event (affecting seven
Fig. 3 Gonococcal DNA content of U.S. NmNG urethritis clade isolates and closely related invasive isolates. Sequence change is measured relative
to M21273 and plotted with respect to the date of isolation. Isolates collected before 2012 are not part of the U.S. NmNG urethritis clade
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genomes) introduced meningococcal-like sequences for
100% of aniA and 64% of norB. The other two events
affected a single genome each and covered short portions
(< 50%) of both aniA and norB; one sequence was inferred
to have originated from N. meningitidis and the other was
inferred to have originated from N. gonorrhoeae. Despite
this diversity of DNA sequences at aniA and norB, all iso-
lates within the U.S. NmNG urethritis clade contained full
length open reading frames of both genes. This occurred
even though the eight closely related invasive disease iso-
lates and the two other NmNG CC11 urethral isolates all
included a frameshift mutation leading to a premature
stop codon in aniA (allele 1) and the eight closely related
invasive meningococcal disease isolates also had a prema-
ture stop codon in norB (allele 149) [8] .
Likewise, at PubMLST loci NEIS1442–1444 (homolo-
gous to ispD, dnaQ, and lplT, respectively), the gonococ-
cal DNA acquired by the U.S. NmNG urethritis clade
was replaced by sequences most similar to N. meningiti-
dis sequences during three recombination events that
affected six genomes. One additional recombination
event occurred at NEIS1444, with a N. gonorrhoeae gen-
ome providing the best match. These subsequent recom-
bination events affected no more than 450/1311 bp of
the lplT homolog, and did not affect NEIS1445 (FixS/
CcoS gene family) and NEIS1446, which had also been
converted to the gonococcal alleles during the initial
recombination event.
A gonococcal antimicrobial resistance determinant was
detected in one isolate
The isolates collected for this study were examined for the
presence of sequence variants that are associated with
reduced antimicrobial susceptibility in N. gonorrhoeae. No
variants were detected at amino acid or nucleotide
positions associated with tetracycline, spectinomycin,
quinolone, cephalosporin, or macrolide resistance. Two
non-CC11 isolates (M38608 and M38636, from rectal and
vaginal swabs, respectively) contained meningococcal mtrR
sequences that are associated with elevated azithromycin
MICs of 2 μg/mL according to NG-STAR [30]. In contrast,
one isolate from the U.S. NmNG urethritis clade collected
in 2015 (M38896) had a gonococcal-like mtrR sequence (al-
lele type 39) that is also associated with elevated azithromy-
cin MICs of 2 μg/mL. This allele conversion occurred as
part of a 7362 bp recombination event (Additional file 3),
which contributed to this isolate having the greatest total
length of gonococcal-like DNA sequences among all iso-
lates in the U.S. NmNG urethritis clade, with 30,208 bp.
Genes for N. meningitidis serogroup B vaccine antigens
are common among the U.S. NmNG urethritis clade
The 209 isolates belonging to the U.S. NmNG urethritis
clade all encode peptides that are targeted by protein-
based vaccines developed to protect against serogroup B
meningococcal disease. All 209 isolates encode NhbA
peptide 20. Two isolates have a stop codon in the fHbp
coding sequence (alleles 1249 and 1250), while 207 en-
code FHbp peptides belonging to subfamily B/variant 1
(peptides 896, 456, and 915 encoded by alleles 1127,
1237, and 1146, respectively). NadA-2/3.2 is encoded by
193 genomes, while it is disrupted by IS1301 in 13
genomes, and by a premature stop codon in three ge-
nomes. The PorA type is P1.5–1,10–8 in 198 genomes,
of which four had an internal stop codon prior to vari-
able region 2. PorA type P1.5–1,10–1 was present in
nine genomes and P1.5–1,10–22 and P1.17,9 were each
present in one genome (Additional file 1).
A small clade of NmNG urethral isolates was also
identified in sublineage 11.2 (Fig. 1, blue star). These
two isolates encoded NhbA peptide 20, but were pre-
dicted not to express FHbp or NadA due to a stop
codon in the fHbp allele 669 and a IS1301 element in
the nadA gene. Both encode PorA type P1.5–1,10–1.
Discussion
The U.S. NmNG urethritis clade is an emerging pathogen
Occasional reports of N. meningitidis urethritis, and
even small clusters of N. meningitidis urethritis, in the
United States date back to the 1940s [2, 4]. Reported
cases have been attributed to diverse lineages [31], many
of which are commonly associated with invasive menin-
gococcal disease. However, the U.S. NmNG urethritis
clade within lineage 11.2 is a new paradigm; the clade is
primarily cultured from cases of male urethritis and only
5 of the 209 known isolates in the clade originated from
cases of invasive disease (Figs. 1 and 2).
Increased numbers of N. meningitidis urethritis iso-
lates have been received by the CDC since 2015, as
awareness was raised by the identification of clusters of
N. meningitidis urethritis at GISP sentinel clinics in Col-
umbus, Ohio and Oakland County, Michigan [11]; these
reports were followed by a request for isolates through
the Epidemic Information Exchange (Epi-X), a secure
communications network for public health officials.
Among the collection of 209 urogenital and rectal iso-
lates received by the CDC in 2015–2016, we identified
two groups of closely related isolates from urethritis
cases: the above-mentioned U.S. NmNG urethritis clade,
and a pair of NmNG isolates constituting a second
lineage 11.2 clade (M39848, M40415; Fig. 1, blue star).
Both of these clades of urethral isolates from the United
States were more closely related to invasive disease
isolates from the U.S. than to the non-U.S. urogenital
isolates listed by Tzeng et al. [8], indicating their separ-
ate evolutionary origins from among lineage 11.2 popu-
lations associated with invasive meningococcal disease.
This repeated observation of phylogenetically separated
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urogenital isolates may indicate that lineage 11.2 has a
greater tendency to colonize the urethra and cause ur-
ethritis than do other N. meningitidis. The non-lineage
11 isolates from the male urogenital system studied were
not closely related to each other or to isolates from the
rectum or the female urogenital system, suggesting that
these lineages do not commonly cause disease at those
body sites. While the prevalence of non-lineage 11
strains among urogenital and rectal infections cannot be
estimated from the isolate collection described here,
many of these isolates were submitted from the same
states as the U.S. NmNG urethritis clade. This suggests
that they are a less common cause of urogenital infec-
tions than the U.S. NmNG urethritis clade, even in the
geographic locations where they were collected.
Overall, these results indicate that the U.S. NmNG ur-
ethritis clade is unusual among N. meningitidis for being
recovered from a large number of urethritis cases. Hav-
ing likely diverged from other N. meningitidis after 2006
and spread to at least 13 states since the most recent
common ancestor existed in 2011 (Fig. 2), this clade of
N. meningitidis appears to be an important emerging
urogenital pathogen.
The U.S. NmNG urethritis clade can cause invasive
meningococcal disease
Capsule expression contributes to virulence during inva-
sive meningococcal disease [8, 19], so the disruption of
the capsule locus in the U.S. NmNG urethritis clade was
expected to limit the risk of invasive meningococcal
disease from this clade. However, by screening genome
sequences obtained through surveillance systems for
invasive meningococcal disease, we identified five non-
groupable isolates from invasive disease cases that
belonged to the U.S NmNG urethritis clade, including
the two earliest representatives, from 2013. Invasive dis-
ease from NmNG strains is generally rare [32] but some
medical conditions and treatments are associated with
higher rates of NmNG infection (e.g. Eculizumab [33]).
The contribution of medical conditions to the risk of in-
vasive disease involving the U.S. NmNG urethritis clade
cannot be assessed with the information available for
these five cases.
Interestingly, the four states in which these five inva-
sive meningococcal disease isolates were collected were
not the same as the states where the greatest number of
N. meningitidis urethritis isolates were collected
(Additional file 1, Fig. 2). Furthermore, the two invasive
disease isolates from Georgia and one from New York
were not most closely related to the urogenital isolates
from the respective states. The identification of invasive
meningococcal disease isolates from the U.S. NmNG
urethritis clade does show that this lineage has the po-
tential to cause invasive infections and its prevalence
should be monitored as a potential contributor to inva-
sive meningococcal disease. However, the frequent de-
tection of the clade in a geographic locality does not
currently appear to indicate an elevated risk of invasive
disease from this pathogen. Increased understanding of
the relationship between N. meningitidis urethritis and
invasive disease can be facilitated by conducting active
surveillance for both invasive disease and urogenital in-
fections in overlapping areas.
Urethral colonization has been proposed to contribute
to invasive meningococcal disease among MSM [9, 10],
and the ability to reduce nitrite has been observed
among isolates collected from invasive cases among
MSM as well as from N. meningitidis urethritis/proctitis
isolates, pointing to a physiological requirement for
colonization of and transmission from the urethra [7, 8].
There is currently no evidence that the U.S. NmNG ur-
ethritis clade is substantially contributing to urethritis
[11] or invasive disease [18] among MSM in the United
States, although two of the five invasive meningococcal
disease case-patients infected by the U.S. NmNG ureth-
ritis clade were MSM. Notable outbreaks of invasive
meningococcal disease among MSM involved serogroup
C (NmC) CC11 strains [7, 15–18], while the CC11 ureth-
ritis isolates evaluated in this study were all nongroupable
and mostly isolated from heterosexual populations [12].
Furthermore, the urogenital isolates examined in this
study were not most closely related to the NmC isolates
collected from the outbreaks of invasive meningococcal
disease among MSM in the United States since 2010 (Fig.
1). Attempts to identify lineages that are associated with
specific diseases can be confounded by bacterial popula-
tion structure, particularly geographic and temporal
variation, so identifying the role, if any, of urethral
colonization in the spread of invasive meningococcal dis-
ease among MSM will require a targeted evaluation of
transmission patterns among this demographic group.
Vaccines may protect against U.S. NmNG urethritis clade
infections
The identification of invasive disease cases involving the
U.S. NmNG urethritis clade indicates the value of
further research into whether the new protein-based
vaccines developed to protect against serogroup B men-
ingococcal disease could provide protection against
infection from this nongroupable clade and other CC11
organisms [34]. The first requirement for vaccine pro-
tection is that the pathogen encodes the genes that
produce the antigens targeted by the vaccine. Both the
MenB-4C and MenB-FHbp vaccines contain FHbp com-
ponents with the same subfamily/variant classification as
the FHbp peptide encoded in most of the U.S NmNG
urethritis clade genomes [35, 36]. For the remaining
components of the MenB-4C vaccine, all clade genomes
Retchless et al. BMC Genomics  (2018) 19:176 Page 8 of 15
encode NhbA and most encode NadA, which may con-
tribute to immunogenicity. However, the PorA peptide
does not match the vaccine component (type 4 in vari-
able region 2), suggesting that it will not contribute to
immunogenicity against this clade [37]. For these
vaccines to provide protection against the U.S. NmNG
urethritis clade, the peptides also are required to be
expressed. Preliminary data (Tzeng Y-L, Stephens DS et
al. unpublished) indicates FHbp is highly expressed on
the surface of clade isolates.
Vaccines developed to protect against serogroup B
invasive disease could also protect against urethritis. A
recent case-control study showed that recipients of a
meningococcal outer-membrane vesicle (OMV) vaccine
had a lower likelihood of N. gonorrhoeae infection than
had their unvaccinated peers [38]. The MenB-4C vaccine
contains the same OMVs.
Genome-based surveillance can rapidly identify emerging
pathogens
Surveillance programs were essential for identifying and
collecting the isolates constituting the U.S. NmNG ur-
ethritis clade, both from urethritis (GISP) and from inva-
sive meningococcal disease cases (Active Bacterial Core
surveillance and Enhanced Meningococcal Surveillance).
While surveillance programs process a large number of
specimens, their methods are defined for the identifica-
tion of specific pathogens from specific clinical speci-
mens. Therefore, they are not necessarily effective at
identifying new emerging pathogens in these specimens.
The increased detection of N. meningitidis among ureth-
ritis specimens was originally noticed at two GISP senti-
nel clinics due to discrepancies in two tests used for the
diagnosis of N. gonorrhoeae infections – specimens con-
taining gram-negative intracellular diplococci had nega-
tive results on a NAAT targeting gonococcal DNA [11].
This process illustrates the value of conducting con-
firmatory tests for pathogens during surveillance activ-
ities. Whole genome sequencing not only allowed
confirmation of N. meningitidis but also enabled high-
resolution typing of this organism.
Whole genome sequencing reveals the evolutionary
process of pathogen emergence
Whole genome sequencing not only allows for the
confirmation of a suspected pathogen, high-resolution
typing, and rapid identification of unexpected pathogens,
but also holds promise for detecting novel pathogens by
sequencing clinical specimens, through either amplicon
deep sequencing or metagenomic approaches. Such
microbiome analyses can be particularly powerful when
disease etiology is unclear.
This study demonstrates the power of whole genome
sequencing to provide precise information about the
evolutionary origin of an emerging pathogen and identify
genetic changes that could contribute to its novel patho-
genicity. The U.S. NmNG urethritis clade is distinct
from the lineage 11.2 strains responsible for outbreaks
of invasive meningococcal disease among MSM in the
United States and Europe as well as from the published
isolates recovered from urethritis cases in Europe. Not
only is the clade nongroupable while the lineage 11.2
isolates associated with the MSM outbreaks and many
prior urethritis cases have been serogroup C, but the
most closely related NmC isolates were not recovered
from the recent outbreaks among MSM (Fig. 1). Instead,
several invasive disease isolates not from MSM from
2007 and 2008 were identified as being closely related to
the urethritis isolates.
The identification of closely related invasive disease
isolates allowed the U.S. NmNG urethritis clade origin
to be placed between late 2005 and early 2012. Several
potentially critical genetic changes occurred during this
period, but the timing of individual changes remains un-
resolved due to the lack of isolates that diverged from
the clade during this period.
While the gain of novel genes appears not to have
contributed to the origin of the U.S. NmNG urethritis
clade, the loss of multiple genes could have had a critical
impact on its pathogenic properties, which has been
observed with other bacterial pathogens [39]. The dis-
ruption of the capsule locus in the U.S. NmNG urethritis
clade results in a nongroupable phenotype, which is
similar to N. gonorrhoeae and may contribute (e.g.
through enhanced mucosal attachment) to the high fre-
quency with which this clade causes urethritis [8, 12].
This deletion completely removed the sialic acid capsule
biosynthesis genes (cssA-C) and part of the serogroup C
capsule polymerase gene (csc). This configuration ap-
pears to be stable among all of the isolates in this clade,
as the respective genes are absent from the genome as-
semblies, but the exact structure of the capsule locus
cannot be determined from short-read data due to the
presence of a IS1301 insertion [8]. Elimination of capsule
expression may play a role in facilitating urethral
colonization, as indicated by the nongroupable pheno-
type in both the U.S. NmNG urethritis clade and the
other two ST-11 urethral isolates from this study (Fig. 1,
blue star), in which capsule expression was disrupted by
a premature stop codon caused by a frameshift mutation
in the capsule translocation gene ctrF.
The only other gene that was disrupted during the
early evolution of the urethritis clade was autA. The
AutA protein is immunogenic and may influence menin-
gococcal autoaggregation and biofilm structure [40, 41];
however, its expression is not a characteristic difference
between N. meningitidis and N. gonorrhoeae, since autA
is phase-variable in both species [41, 42]. A 3.7 kb
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recombination event introduced gonococcal DNA at the
locus responsible for nitrite-dependent anaerobic growth
(NEIS1548-NEIS1549), replacing aniA and most of norB,
while eliminating internal stop codons in both genes [8].
The reconstitution of the aniA ORF can enable nitrite-
dependent anaerobic growth in N. meningitidis, and
several isolates from the U.S. NmNG urethritis clade have
been shown to possess this capability [8]. Nitrite-
dependent anaerobic growth has been proposed to be an
important contributor to urethral colonization by some N.
meningitidis [7], and it is a fundamental distinction be-
tween N. gonorrhoeae and N. meningitidis in general [43].
Another acquisition of gonococcal DNA covered a
3.1 kb region that included five genes (NEIS1442-
NEIS1446). This included a potential coding region for a
61-residue protein of the FixS/CcoS family (NEIS1445),
which is essential for the maturation of cbb3-type cyto-
chrome oxidase [44]. Cytochrome cbb3 oxidase reduces
oxygen as an alternative pathway to AniA (NirK)-medi-
ated reduction of nitrite in Neisseria, but it can also act
as an electron donor to AniA in N. gonorrhoeae [45].
The other ORFs impacted by this recombination event
show homology to an isoprenoid synthesis gene (ispD),
the DNA polymerase subunit epsilon (dnaQ), and a lyso-
phospholipid transporter (lplT). Subsequent acquisitions
of meningococcal DNA at this locus did not include the
FixS/CcoS family coding sequence, even as they did in-
clude the ispD and dnaQ homologs as well as one-third
of the lplT homolog. This reversion to meningococcal
sequences at ispD, dnaQ, and lplT among urethral iso-
lates may indicate that the gonococcal version of these
genes do not contribute to urethral colonization or ur-
ethritis pathogenicity, but that the FixS/CcoS family cod-
ing sequence or its upstream sequences do. If so, the
contribution may not be due to changes in the FixS/
CcoS family protein, which only acquired a single amino
acid polymorphism; instead, the contribution of gono-
coccal FixS may result from gene expression changes,
which could be mediated by upstream sequences or the
eleven synonymous polymorphisms in the gene [46].
Acquisitions of gonococcal DNA have continued fol-
lowing the establishment of the U.S. NmNG urethritis
clade (Fig. 3, Additional file 4). These additional gono-
coccal sequence variants are only present in a fraction
(< 30) of the isolates collected during surveillance. Con-
tinued surveillance and isolate collection will enable
tracking of whether these gonococcal sequences become
more frequent in urethritis-associated N. meningitidis.
Of note, a single isolate from the U.S. NmNG urethritis
clade contained an mtrR promoter and coding sequence
that had been associated with decreased susceptibility to
azithromycin in N. gonorrhoeae. This isolate was col-
lected in 2015, and this mtrR sequence was not detected
in any isolates collected in 2016.
Niche invasion and speciation
N. gonorrhoeae has been proposed to have originated as
a clone of the N. meningitidis progenitor that switched
from primarily colonizing the nasopharynx to primarily
colonizing the urogenital system [20]. While each spe-
cies is capable of colonizing the primary habitat of the
other, ecological separation could contribute to the rarity
of gene flow between these two species [20, 21], with
either physical separation or incompatible adaptations
being responsible. Molecular mechanisms could also
contribute to the genetic isolation of the species, includ-
ing the binding-specificity of the ComP protein with
species-specific DNA uptake sequences, the activity of
species-specific restriction endonucleases, and the ten-
dency of sequence divergence to inhibit homologous re-
combination [47]. The detection of multiple gonococcal
DNA sequences in recombinant genomic regions within
the U.S. NmNG urethritis clade suggests that one or
more of these barriers may have been weakened, and
gene flow from N. gonorrhoeae to the U.S. NmNG ureth-
ritis clade has contributed to the emergence of this clade
as a urogenital pathogen.
Orogenital contact appears to play a role in the initi-
ation of urethral colonization, as most patients in the
initial Columbus study reported oral sex in the month
before diagnosis [12]. Furthermore, one isolate in the
U.S. NmNG urethritis clade (Fig. 2) was obtained from
an oral swab provided by a sexual partner of a meningo-
coccal urethritis patient. Additional isolates belonging to
the U.S. NmNG urethritis clade were recovered from the
rectum and female urogenital system, suggesting that it
may also be able to colonize these sites. However,
genital-to-oral transmission or genital-to-genital trans-
mission have not been investigated, leaving open the
possibility that urethral colonization is an evolutionary
dead-end for N. meningitidis. The importance of ureth-
ral colonization to the natural history of the U.S. NmNG
urethritis clade, the risk of this clade causing urogenital
disease in females, and the transmission dynamics of the
clade in both a urogenital and nasopharyngeal niche are
areas of future study.
Conclusions
A novel clade of N. meningitidis has emerged in the past
decade as an important male urethritis-associated patho-
gen. During this time, the clade has spread among sev-
eral states and gained gonococcal genetic material,
potentially facilitating urethral colonization. However,
the U.S. NmNG urethritis clade is also capable of caus-
ing invasive meningococcal disease, and the risk posed
as a urethral pathogen and invasive meningococcal dis-
ease pathogen is still unclear. To date the clade has not
acquired common gonococcal antimicrobial resistance
factors. However, to the extent that the ecology and
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clinical presentation of the NmNG urethritis clade mir-
rors that of gonococcal infections, the evolutionary
forces that resulted in high rates of antimicrobial resist-
ance among N. gonorrhoeae may lead to the same result
among these N. meningitidis. Assessment of disease risk
and the development of control strategies will be facili-
tated by a greater understanding of the prevalence of
colonization by the U.S. NmNG urethritis clade and the
modes of transmission. The results reported here
illustrate the value of applying whole genome sequen-
cing to disease surveillance in order to quickly identify
and characterize emerging pathogens and track their
evolution.
Methods
Isolate collection and characterization
Isolates within the CDC N. meningitidis strain collection
that belonged to the U.S. NmNG urethritis clade were
identified using a SNP-based parsimony phylogeny (de-
scribed below) to compare 343 CC11 N. meningitidis
isolates with available genome sequences to the isolates
described by Bazan et al. [12]. The 343 CC11 isolates
were collected in the USA between 1994 and 2016; 304
were associated with invasive cases and 39 were not.
Isolates were considered closely related to the U.S.
NmNG urethritis clade if they were at least as closely re-
lated to the clade as M16917, which had previously been
identified as the most closely related isolate [12]. These
isolates are described in Additional file 1.
Following the initial report of clusters of meningococ-
cal urethritis [11] the CDC requested that state and local
public health departments report any urethritis cases
that tested both GNID positive and NAAT negative for
N. gonorrhoeae and submit associated isolates to the
CDC for characterization. The request was made on
February 17, 2016 through the Epidemic Information
Exchange (Epi-X) [48], CDC’s system for rapid and se-
cure exchange of public health information between
CDC and state and local health departments. GISP
isolates were collected as described previously [12]. Uro-
genital and rectal isolates collected after January 1, 2015
and received before September 30, 2016 were included
in this analysis, for 209 isolates (Table 1, Additional file 1).
Three additional NmNG invasive disease isolates from
2014 and 2015 were selected from the CDC strain collec-
tion, sequenced, and included in the analysis. Isolates were
confirmed to be N. meningitidis using species-specific
real-time PCR, while serogroup was identified using slide
agglutination and confirmed using real-time PCR [49].
This study also included meningococcal genome se-
quences previously published on PubMLST.org [50] and
NCBI BioProjects PRJNA400487 and PRJNA378732, as
depicted in Additional file 1. These included genomes of
41 non-U.S. CC11 isolates (21 from the male urogenital
system, 12 from female urogenital system, and eight
from MSM invasive cases) described by Tzeng et al. [8],
4 NmNG CC11 urethritis isolates from Indiana [8, 13]
and 74 genomes from U.S. CC11 invasive disease isolates
(31 from four invasive meningococcal disease outbreaks
among MSM from 2009 to 2016 [16–18, 26] and 43
from invasive cases in the same geographical region as
the outbreaks among MSM). FAM18 [51] and an isolate
from the serogroup W Hajj-related outbreak in 2000,
M07149 [52], were included as phylogenetic reference
genomes.
If the body site from which an isolate was collected
was undocumented, then the body site was inferred from
the disease associated with the isolate. Isolates were
grouped by body site as follows: male urogenital system
(urine, urethral swab, and urethritis-associated body
site), female urogenital system (vaginal swab, cervical
swab, and vaginal discharge-associated body site), mouth
and throat (oral swab and oropharyngeal swab), nor-
mally sterile site (blood, CSF, joint fluid, or specimens
associated with meningitis or septicemia), eye (eye
swab), and rectal (rectal swab).
Genome sequencing and characterization
Whole genome sequence data were generated as
250 bp paired-end reads using either an Illumina
HiSeq 2500 or MiSeq and submitted to NCBI under
BioProject PRJNA324131. DNA was extracted from
plated isolates using ArchivePureTM DNA purifica-
tion kit (5 prime, Gaithersburg MD, USA), sheared to
600 bp using a Covaris LE220 focused ultrasonicator
(Covaris Inc., Woburn, MA), and libraries were
constructed using the NEBNext Ultra DNA library
preparation kit (New England Biolabs, Ipswich, MA,
USA). Reads were trimmed with CutAdapt v1.8 [53]
and assembled with SPAdes v3.7 [54]. Locus annota-
tions were obtained from both PubMLST [50] and
Prokka v1.11 [55]. Gene content variation was examined
using the PubMLST.org GenomeComparator tool. Multi-
locus Sequence Typing (MLST) alleles and outer mem-
brane proteins were identified by searching assembled
genomes with PubMLST allele lists using BLAST v2.2.30
[56]. Porin A (PorA), Porin B (PorB), and Ferric entero-
bactin transport (FetA) types are defined by their respect-
ive variable regions [57]. Neisseria adhesin A (NadA) is
identified by variant and peptide ID, as suggested by Bam-
bini et al. [58]. Disruption of NadA by IS1301 was inferred
if portions of the NadA gene were identified in two gen-
omic locations, each adjacent to a sequence from IS1301.
Genome assemblies downloaded from PubMLST were
not assessed for IS1301 insertions. Both Neisserial
Heparin Binding Antigen (NhbA) and Factor H binding
protein (FHbp) are identified by their PubMLST peptide
identifiers.
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Identification of variants associated with N. gonorrhoeae
antimicrobial resistance
To determine if any of the meningococcal genomes
contained sequences related to gonococcal-specific re-
sistance, raw reads were mapped to the Neisseria gonor-
rhoeae FA19 reference genome using CLC Genomics
Workbench (CLC bio, Aaarhus, Denmark), and variants
were called using the fixed ploidy variant detection
model. Variants associated with resistance or reduced
susceptibility to penicillin (penA D354-insertion; ponA
L421P), tetracycline (rpsJ V57 M/L/Q), spectinomycin
(rpsE V25-deletion, K26E), quinolones (parC S87R/N/I;
gyrA D95G/A/N, S91F), macrolides (mtrR promoter re-
gion A-deletion, interspecies mosaic alleles; mtrR
G45D), and cephalosporins (penA mosaic XXXIV; ponA
L421P; porB A121N) were examined. Macrolide resist-
ance in N. gonorrhoeae is also associated with variants in
23S rRNA (C2611T and A2059G), and variants were
examined using a signal ratio analysis as previously de-
scribed [59]. Sequences from isolates exhibiting known
gonococcal variants were subsequently subjected to
BLAST [56] and Neisseria gonorrhoeae Sequence Typing
for Antimicrobial Resistance (NG-STAR) [30] analyses
for further characterization.
Phylogenetic analysis
SNP-based parsimony phylogenies (Fig. 1) were inferred
from genome assemblies by the kSNP v3.0 pipeline [60].
kSNP examines all 25 bp sequences in each genome (k-
mers) and reports core single nucleotide polymorphisms
(SNPs) for all sets of k-mers that differ only at the
central (i.e. 13th) base, and are present in all genomes.
The collection of identified SNPs was then analyzed by
RAxML v7.3 [61] to identify the most parsimonious
phylogeny.
A time-measured phylogeny (Fig. 2) was inferred using
BEAST v1.8.3 [27] based on a recombination-masked
core genome alignment of the 213 U.S. NmNG urethritis
clade and closely related isolates. The alignment was
generated by first calling consensus nucleotide se-
quences for each genome from Illumina short read data
using the Snippy v3.1 pipeline [62], which both mapped
reads and called consensus nucleotides based on the
complete, circular genome sequence of the closely re-
lated isolate M21273 as a reference. Genomes obtained
from PubMLST as assemblies cannot be used in this
analysis, since this requires read data. One isolate was
removed from the alignment due to low coverage of the
reference genome (M39066, 83% coverage), and the
remaining isolates each exceeded 93% coverage. Columns
with gaps or ambiguous bases were masked, retaining a
1,972,278 bp core alignment (89% of M21273) with 27,271
polymorphic sites. Recombinant tracts were masked using
Gubbins v1.4.1 [63], which identifies recombination based
on the chromosomal clustering of mutations that occur
on the same branch of a phylogenetic tree. Gubbins was
run with up to 10 iterations and a minimum of 5 SNPs in
a recombination tract, identifying 308 recombination
events on 115 branches with 0.155 recombination events
per point mutation events and 16.48 polymorphisms
introduced by recombination per polymorphism from
mutation, leaving 1343 polymorphic sites. To evaluate the
impact of recombination masking on the ability to predict
the date that an isolate was collected, the correlation
between isolation date and root-to-tip distance was
established with TempEst v1.5 [64] based on maximum
likelihood phylogenies inferred from the masked and
unmasked alignments (r = 0.76 and 0.52, respectively)
using RAxML v8.2.4 with the “GTRGAMMAX” substitu-
tion model and “autoMRE” bootstrap stopping algorithm
[61]. The recombination-masked Gubbins alignment was
analyzed by BEAST v1.8.3 [27] to perform Bayesian infer-
ence of parameters in the HKY substitution model, using
a chain length of 108; the estimated clock rate was 3.03 ×
10− 6 substitutions per year (Effective Sample Size = 751)
and estimated kappa was 7 (Effective Sample Size = 8689).
Recombinant regions were identified on the BEAST-
generated tree using ClonalFrameML 1.25 [29], which
uses a maximum likelihood phylogenetic model to identify
recombination events that introduced clusters of polymor-
phisms on the chromosome. This method is known to
undercount recombination events that introduce a small
number of polymorphisms [29]; however, ClonalFrameML
infers the genome sequence of all ancestors in the phylo-
genetic tree and can identify repeated recombination
events that occurred at the same locus. The percentage of
nucleotides changed by a recombination event was calcu-
lated as the percentage of nucleotides in the recombinant
region that differed between the recombinant node and its
parent node in the tree, excluding nucleotide positions
that had been masked because of gaps or ambiguous
bases. The recombinant sequences identified by Clonal-
FrameML were BLAST-searched against the NCBI RefSeq
Genomes database (retrieved February 1, 2017) to identify
potential sources of recombination [56]. Recombinant se-
quences were inferred to have originated from a different
species if they matched a sequence from that species with
at least 0.5% greater sequence identity than any match to
N. meningitidis (including the outgroup sequence M21273
and the inferred ancestral sequence from ClonalFra-
meML), with the remaining recombinant sequences being
identified as having ambiguous origin.
Phylogenetic trees were drawn by iTOL [65], and analyses
made use of SciPy v0.18 [66] and BioPython v1.68 [67].
The findings and conclusions in this report are those
of the authors and do not necessarily represent the offi-
cial position of the Centers for Disease Control and
Prevention.
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Additional files
Additional file 1: List of 353 isolates included in analyses of the U.S.
NmNG urethritis clade, including sequence accession information, and
provenance, serogroup, molecular typing, and impact of recombination
events where available. (XLSX 53 kb)
Additional file 2: Depiction of isolate collection included in each analysis.
Regions are not to scale. All Isolates are included in phylogenetic analysis
for Fig. 1 (n = 353). The bases for inclusion are listed in the margins. Isolates
belonging to the U.S. NmNG urethritis clade are outlined, and isolates
included in Fig. 2 are identified with diagonal hatching. Cross (+) identifies
isolates that were excluded from analysis in Fig. 2 due to inappropriate data
format. Asterisk (*) marks an isolate that was excluded from analysis in Fig. 2
due to insufficient data quality. (TIFF 127 kb)
Additional file 3: Homologous allele replacements identified by
ClonalFrameML, including gene annotations and the results of searching
the BLAST RefSeq genomic database. The “Dictionary” worksheet defines
the columns used in the “Recombination events” worksheet. (XLSX 230 kb)
Additional file 4: Loci affected by homologous allele replacement. The
summary worksheet identifies loci where > 50% of the length was involved
in a recombination event affecting the ancestor of at least one genome was
inferred to have originated with N. gonorrhoeae. The “Dictionary” worksheet
defines the columns used in the two “Recombinant loci” worksheets.
(XLSX 662 kb)
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